BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities... BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. Show more
FLORHAM PARK, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (βBeyondSpringβ or the βCompanyβ), a clinical-stage global biopharmaceutical company developing innovative...
- Statistically Significant and Clinically Meaningful Efficacy Data with Favorable Benefit/Risk ratio from DUBLIN-3 Phase 3 Study of Plinabulin plus Docetaxel vs. Docetaxel in EGFR Wild-Type NSCLC...
FLORHAM PARK, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (βBeyondSpringβ or the βCompanyβ), a clinical-stage global biopharmaceutical company focused on developing...
The SEED-Eisai Research Collaboration leverages Eisaiβs leading expertise in neurodegeneration and cancer. SEED is entitled to receive upfront and milestone payments of up to $1.5 billion plus...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.22 | -9.5652173913 | 2.3 | 2.54 | 2.05 | 15912 | 2.16695371 | CS |
4 | 0.13 | 6.66666666667 | 1.95 | 2.54 | 1.8868 | 26200 | 2.09351807 | CS |
12 | -0.35 | -14.4032921811 | 2.43 | 2.6 | 1.695 | 24392 | 2.09814705 | CS |
26 | -1.04 | -33.3333333333 | 3.12 | 3.75 | 1.695 | 53184 | 2.58808898 | CS |
52 | 1.3207 | 173.936520479 | 0.7593 | 4 | 0.6534 | 96357 | 2.2581013 | CS |
156 | -13.2006 | -86.3879690588 | 15.2806 | 17.98 | 0.542 | 384422 | 4.5503852 | CS |
260 | -15.84 | -88.3928571429 | 17.92 | 33 | 0.542 | 457307 | 13.19087615 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.